Marginal Zone Lymphoma (MZL)
Also known as: MZL / Marginal Zone Lymphomas / Marginal Zone Lymphoma(MZL) / Lymphoma, Marginal Zone / Marginal Zone Lymphoma / Marginal Lymphoma / Marginal zone lymphoma -RETIRED- / Marginal zone B-cell lymphoma (morphologic abnormality) / Marginal zone lymphoma (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB09053 | Ibrutinib | An antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia. |
DB00480 | Lenalidomide | A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. |